Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 09, 2019

SELL
$217.44 - $243.88 $73,277 - $82,187
-337 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$216.71 - $338.96 $3,684 - $5,762
-17 Reduced 4.8%
337 $80,000
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $55,366 - $65,985
-215 Reduced 37.79%
354 $103,000
Q1 2018

May 11, 2018

SELL
$260.13 - $367.91 $5,202 - $7,358
-20 Reduced 3.4%
569 $156,000
Q4 2017

Feb 20, 2018

SELL
$307.64 - $344.58 $76,294 - $85,455
-248 Reduced 29.63%
589 $188,000
Q3 2017

Nov 13, 2017

SELL
$281.15 - $329.69 $11,808 - $13,846
-42 Reduced 4.78%
837 $262,000
Q2 2017

Aug 14, 2017

BUY
N/A
879
879 $239,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Seven Bridge Financial Group, LLC Portfolio

Follow Seven Bridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.